View More View Less
  • 1 Semmelweis Egyetem, Fogorvostudományi Kar Arc-, Állcsont-, Szájsebészeti és Fogászati Klinika, Orálpatológiai Részleg Budapest Mária u. 52. 1085
Open access

Az ösztrogénhormont hosszú ideig a női élettani folyamatok és a szaporodás legfontosabb szereplőjének tartották. Manapság már jól ismert tény, hogy a női nemi hormon döntő szerepet játszik a sejtdifferenciálódás és -proliferáció génregulációjában. A női nemi hormonok és a rák kapcsolatát illetően az irodalmi adatok nem egységesek. A daganatkutatás homlokterében vannak az erősen ösztrogénfüggő daganatok, amelyekről az a vélemény alakult ki, hogy hormonálisan indukálódnak. Ennek ellenére kiderült, hogy az ösztrogén carcinogen hatását bizonyító eredmények ellentmondásosak. Az utóbbi években klinikai vizsgálatok igazolták, hogy a posztmenopauzális nők hormonterápiája jótékony, rákmegelőző hatást fejt ki számos szervben, még a női emlőben is. Az újabban felfedezett kapcsolat az ösztrogénhiány és a szájüregi rák kockázata között ellentétben áll a hagyományos ösztrogénindukált rák koncepciójával. A mérsékelten és erősen ösztrogéndependens tumoroknak eltérő epidemiológiai sajátosságaik vannak. Az úgynevezett dohányzásfüggő daganatok a mérsékelten ösztrogénfüggő szervekből indulnak ki. Túlnyomó többségük a késői posztmenopauzális periódusban jelentkezik, amikor az ovárium ösztrogéntermelése már jelentősen csökkent. Ezzel szemben az erősen ösztrogénfüggő szervek rákjai (például emlő, endometrium és ovárium) premenopauzális és posztmenopauzális esetekben egyaránt jelentkeznek. A különböző epidemiológiai adatok ellenére feltételezhető, hogy a tumoriniciáció hátterében a génregulációs zavar nem alakulhat ki teljesen ellentétes ösvényeken. Feltételezhető, hogy a mérsékelten ösztrogénfüggő szervekben a súlyos, az erősen ösztrogéndependensekben pedig már az enyhe ösztrogénhiány is rákiniciációt provokálhat. Mind a dohányzásfüggő, mind a hormondependens rákokon tapasztalt új megfigyelések ugyanahhoz a konverzióhoz vezetnek; nem az ösztrogén, hanem a hiánya provokálja a rákiniciációt.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Suba, Zs.: Gender-related hormonal risk factors for oral cancer. Pathol. Oncol. Res., 2007, 13 , 195–202.

    Suba Zs. , 'Gender-related hormonal risk factors for oral cancer ' (2007 ) 13 Pathol. Oncol. Res. : 195 -202.

    • Search Google Scholar
  • Kumar, V., Abbas, A. K., Fausto, N. és mtsa: Robbins basic pathology. 8th edition Saunders, Elsevier, 2007.

    Fausto N. , '', in Robbins basic pathology , (2007 ) -.

  • Montag, A., Kumar, V.: The female genital system and breast Chapter 19. In Kumar, V., Abbas, A. K., Fausto, N., Mitchell, R. N. (eds.): Robbins basic pathology. 8th edition. Saunders, Elsevier, 2007.

    Kumar V. , '', in Robbins basic pathology , (2007 ) -.

  • Muti, P., Quattrin, T., Grant, B. J. B. és mtsai: Fasting glucose is a risk factor for breast cancer. Cancer Epidemiol Biomark & Prev., 2002, 11 , 1361–1368.

    Grant B. J. B. , 'Fasting glucose is a risk factor for breast cancer ' (2002 ) 11 Cancer Epidemiol Biomark & Prev. : 1361 -1368.

    • Search Google Scholar
  • Soliman, P. T., Oh, J. C., Schmeler, K. M. és mtsai: Risk factors for young premenopausal women with endometrial cancer. Obstet. Gynecol., 2005, 105 , 575–580.

    Schmeler K. M. , 'Risk factors for young premenopausal women with endometrial cancer ' (2005 ) 105 Obstet. Gynecol. : 575 -580.

    • Search Google Scholar
  • Suba, Zs.: Re-evaluation of the epidemiological associations of female sexual steroids and cancer risk. Chapter 6. In Estrogen versus cancer. Nova Science Publishers, Inc., New York, 2009, (in press).

    Suba Zs. , '', in Estrogen versus cancer , (2009 ) -.

  • Suba, Zs.: Insulin resistance, hyperinsulinemia and cancer risk. Chapter 2. In Estrogen versus cancer. Nova Science Publishers, Inc., New York, 2009, (in press).

    Suba Zs. , '', in Estrogen versus cancer , (2009 ) -.

  • American Institute For Cancer Research/World Cancer Research Fund: Food, nutrition and the prevention of cancer: a global perspective. American Institute of Cancer Research, Washington, DC, 2002, 252–287.

    '', in Food, nutrition and the prevention of cancer: a global perspective , (2002 ) -.

  • Key, T. J., Applyby, P. N., Reeves, G. K.: Body mass index, serum sex hormones and breast cancer risk in postmenopausal women. J. Natl. Cancer Inst., 2003, 95 , 1218–1226.

    Reeves G. K. , 'Body mass index, serum sex hormones and breast cancer risk in postmenopausal women ' (2003 ) 95 J. Natl. Cancer Inst. : 1218 -1226.

    • Search Google Scholar
  • Berrino, F., Muti, P., Micheli, A. és mtsai: Serum sex hormon levels after menopause and subsequent breast cancer. J. Natl. Cancer Inst., 1996, 88 , 291–296.

    Micheli A. , 'Serum sex hormon levels after menopause and subsequent breast cancer ' (1996 ) 88 J. Natl. Cancer Inst. : 291 -296.

    • Search Google Scholar
  • Kabuto, M., Akiba, S., Stevens, R. G. és mtsai: A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol. Biomark & Prev., 2000, 9 , 575–579.

    Stevens R. G. , 'A prospective study of estradiol and breast cancer in Japanese women ' (2000 ) 9 Cancer Epidemiol. Biomark & Prev. : 575 -579.

    • Search Google Scholar
  • La Vecchia, C., Brinton, L. A., McTiernan, A.: Menopause, hormone replacement therapy and cancer. Maturitas, 2001, 39 , 97–115.

    McTiernan A. , 'Menopause, hormone replacement therapy and cancer ' (2001 ) 39 Maturitas : 97 -115.

    • Search Google Scholar
  • Brekelmans, C. T.: Risk factors and risk reduction of breast and ovarian cancer. Curr. Opin Obstet. Gynecol., 2003, 15 , 63–68.

    Brekelmans C. T. , 'Risk factors and risk reduction of breast and ovarian cancer ' (2003 ) 15 Curr. Opin Obstet. Gynecol. : 63 -68.

    • Search Google Scholar
  • Bloomgarden, Z. T., Second World Congress on the Insulin Resistance Syndrome: Mediators, pediatric insulin resistance, the polycystic ovary syndrome, and malignancy. Diabetes Care, 2005, 28 , 1821–1830.

    Bloomgarden Z. T. , 'Mediators, pediatric insulin resistance, the polycystic ovary syndrome, and malignancy ' (2005 ) 28 Diabetes Care : 1821 -1830.

    • Search Google Scholar
  • Greenle, R. T., Murray, T., Bolden, S. és mtsa: Cancer statistics. CA Cancer J. Clin., 2000, 50 , 7–33.

    Bolden S. , 'Cancer statistics ' (2000 ) 50 CA Cancer J. Clin. : 7 -33.

  • Weiderpass, E., Gridley, G., Persson, I. és mtsai: Risk of endometrial and breast cancer in patients with diabetes mellitus. Int. J. Cancer, 1997, 1 , 360–363.

    Persson I. , 'Risk of endometrial and breast cancer in patients with diabetes mellitus ' (1997 ) 1 Int. J. Cancer : 360 -363.

    • Search Google Scholar
  • Horn, L. C., Dietel, M., Einenkel, J.: Hormone replacement therapy (HRT) and endometrial morphology under consideration of the different molecular pathways in endometrial carcinogenesis. Eur. J. Obst. Gyn. Repr. Biol., 2005, 122 , 4–12.

    Einenkel J. , 'Hormone replacement therapy (HRT) and endometrial morphology under consideration of the different molecular pathways in endometrial carcinogenesis ' (2005 ) 122 Eur. J. Obst. Gyn. Repr. Biol. : 4 -12.

    • Search Google Scholar
  • Anderos, G. L., Judd, H. L., Kaunitz, A. M. és mtsai: Womens’s Health Intitative Investigator Effects of estrogen plus progestin on gynaecologic cancers and associated diagnostic producers: The Women’s Health Intitative randomised trial. JAMA, 2003, 290 , 1739–1748.

    Kaunitz A. M. , 'Womens’s Health Intitative Investigator Effects of estrogen plus progestin on gynaecologic cancers and associated diagnostic producers: The Women’s Health Intitative randomised trial ' (2003 ) 290 JAMA : 1739 -1748.

    • Search Google Scholar
  • Ito, K., Utsunomiya, H., Yaegashi, N. és mtsa: Biological roles of estrogen and progesterone in human endometrial carcinoma – new developments in potential endocrine therapy for endometrial cancer. Endocrine Journal, 2007, 54 , 667–679.

    Yaegashi N. , 'Biological roles of estrogen and progesterone in human endometrial carcinoma – new developments in potential endocrine therapy for endometrial cancer ' (2007 ) 54 Endocrine Journal : 667 -679.

    • Search Google Scholar
  • Lax, S. F., Kendall, B., Tashiro, H. és mtsai: Analysis of p53 and K-ras mutations and microsatellite instability suggests distinct molecular genetic pathways in the pathogenesis of uterine endometrioid and serous carcinoma. Cancer, 2000, 88 , 814–824.

    Tashiro H. , 'Analysis of p53 and K-ras mutations and microsatellite instability suggests distinct molecular genetic pathways in the pathogenesis of uterine endometrioid and serous carcinoma ' (2000 ) 88 Cancer : 814 -824.

    • Search Google Scholar
  • WHO Classification on Pathology and Genetics. In Tavassoli, F. A., Devile, P. (eds.): Tumours of the breast and female genital organs. WHO Publications, Geneva, Switzerland, 2003.

  • Varras, M., Polyzos, D., Akviris, C.: Effects of tamoxifen on the human female genital tract: Review of the literature. Eur. J. Gynaecol. Oncol., 2003, 24 , 258–268.

    Akviris C. , 'Effects of tamoxifen on the human female genital tract: Review of the literature ' (2003 ) 24 Eur. J. Gynaecol. Oncol. : 258 -268.

    • Search Google Scholar
  • Cirisano, F. D., Robboy, S. J., Dodge, R. K. és mtsai: The outcome of state I–II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrial carcinoma. Gynecol. Oncol., 2000, 77 , 55–65.

    Dodge R. K. , 'The outcome of state I–II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrial carcinoma ' (2000 ) 77 Gynecol. Oncol. : 55 -65.

    • Search Google Scholar
  • Nand, S. L., Webster, M. A., Baber, R.: The Oestrogen/Provera Study Group. Bleeding pattern and the endometrial changes during continuous combined hormone replacement therapy. Obstet. Gynecol., 1998, 91 , 678–684.

    Baber R. , 'Bleeding pattern and the endometrial changes during continuous combined hormone replacement therapy ' (1998 ) 91 Obstet. Gynecol. : 678 -684.

    • Search Google Scholar
  • Sitruk-Warre, R.: Progestogens in hormonal replacement therapy: New molecules, risks and benefits. Menopause, 2002, 9 , 6–15.

    Sitruk-Warre R. , 'Progestogens in hormonal replacement therapy: New molecules, risks and benefits ' (2002 ) 9 Menopause : 6 -15.

    • Search Google Scholar
  • Dietel, M., Lewis, M. A., Shapiro, S.: Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review. Human Reprod., 2005, 20 , 2052–2060.

    Shapiro S. , 'Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review ' (2005 ) 20 Human Reprod. : 2052 -2060.

    • Search Google Scholar
  • Bosetti, C., Negri, E., Franceschi, S. és mtsai: Diet and ovarian cancer risk: a case-control study in Italy. Int. J. Cancer, 2001, 93 , 911–915.

    Franceschi S. , 'Diet and ovarian cancer risk: a case-control study in Italy ' (2001 ) 93 Int. J. Cancer : 911 -915.

    • Search Google Scholar
  • Risch, H. A.: Hormone replacement therapy and the risk of ovarian cancer. Gynecol. Oncol., 2002, 86 , 115–117.

    Risch H. A. , 'Hormone replacement therapy and the risk of ovarian cancer ' (2002 ) 86 Gynecol. Oncol. : 115 -117.

    • Search Google Scholar
  • Whittemore, A. S., Harris, R., Itnyre, J.: Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IL invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am. J. Epidemiol., 1992, 136 , 1184–1203.

    Itnyre J. , 'Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IL invasive epithelial ovarian cancers in white women ' (1992 ) 136 Am. J. Epidemiol. : 1184 -1203.

    • Search Google Scholar
  • Negri, E., Tzonou, A., Beral, V. és mtsai: Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies. Int. J. Cancer, 1999, 80 , 848–851.

    Beral V. , 'Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies ' (1999 ) 80 Int. J. Cancer : 848 -851.

    • Search Google Scholar
  • Rodriguez, C., Patel, A. V., Calle, E. E. és mtsa: Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. J. Am. Med. Assoc., 2001, 285 , 1460–1465.

    Calle E. E. , 'Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women ' (2001 ) 285 J. Am. Med. Assoc. : 1460 -1465.

    • Search Google Scholar
  • Gambacciani, M., Rosano, G. M., Monteleone, P. és mtsai: Clinical relevance of the HERS trial. Lancet, 2002, 360 , 641.

    Monteleone P. , 'Clinical relevance of the HERS trial ' (2002 ) 360 Lancet : 641 -.

  • Lacey, J. V., Mink, P. J., Lubin, J. H. és mtsai: Menopausal hormone replacement therapy and risk of ovarian cancer. J. Am. Med. Assoc., 2002, 288 , 334–341.

    Lubin J. H. , 'Menopausal hormone replacement therapy and risk of ovarian cancer ' (2002 ) 288 J. Am. Med. Assoc. : 334 -341.

    • Search Google Scholar
  • Schapiro, S.: False alarm: postmenopausal hormone therapy and ovarian cancer. Climacteric., 2007, 10 , 466–470.

    Schapiro S. , 'False alarm: postmenopausal hormone therapy and ovarian cancer ' (2007 ) 10 Climacteric. : 466 -470.

    • Search Google Scholar
  • Grady, D.: Postmenopausal hormones – therapy for symptoms only. New Engl. J. Med., 2003, 348 , 1–3.

    Grady D. , 'Postmenopausal hormones – therapy for symptoms only ' (2003 ) 348 New Engl. J. Med. : 1 -3.

    • Search Google Scholar
  • Collaborative Group on Hormonal Factors in Breast Cancer: Collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet, 1997, 350 , 1047–1059.

    'Collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer ' (1997 ) 350 Lancet : 1047 -1059.

    • Search Google Scholar
  • Anderson, G. L., Limacher, M., Assaf, A. R. és mtsai: Women’s Health Intitative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Intitative randomized controlled trial. JAMA, 2004, 291 , 1701–1712.

    Assaf A. R. , 'Women’s Health Intitative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Intitative randomized controlled trial ' (2004 ) 291 JAMA : 1701 -1712.

    • Search Google Scholar
  • Olsson, H., Bladström, A. M., Ingvar, C.: Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy? Obstet. Gynecol., 2003, 102 , 565–570.

    Ingvar C. , 'Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy? ' (2003 ) 102 Obstet. Gynecol. : 565 -570.

    • Search Google Scholar
  • Adami, H. O., Signorello, L. B., Trichopolos, D.: Towards an understanding of breast cancer etiology. Semin. Cancer Biol., 1998, 8 , 255–262.

    Trichopolos D. , 'Towards an understanding of breast cancer etiology ' (1998 ) 8 Semin. Cancer Biol. : 255 -262.

    • Search Google Scholar
  • Hofseth, L. J., Raafat, A. M., Osuch, J. R. és mtsai: Hormone replacement therapy with estrogen or estrogen plus medroxy-progesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J. Clin. Endocrinol. Metab., 1999, 84 , 4559–4565.

    Osuch J. R. , 'Hormone replacement therapy with estrogen or estrogen plus medroxy-progesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast ' (1999 ) 84 J. Clin. Endocrinol. Metab. : 4559 -4565.

    • Search Google Scholar
  • Li, C. I., Weiss, N. S., Stanford, J. L. és mtsa: Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer, 2000, 88 , 2570–2577.

    Stanford J. L. , 'Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women ' (2000 ) 88 Cancer : 2570 -2577.

    • Search Google Scholar
  • Wisemann, R. A.: Brest cancer hypothesis: a single cause for the majority of cases. J. Epidemiol. Community Haelth, 2000, 54 , 851–858.

    Wisemann R. A. , 'Brest cancer hypothesis: a single cause for the majority of cases ' (2000 ) 54 J. Epidemiol. Community Haelth : 851 -858.

    • Search Google Scholar
  • Spratt, J. S., Meyer, J. S., Spratt, J. A.: Rates of growth of human solid neoplasms: part I. J. Surg. Oncol., 1995, 60 , 137–146.

    Spratt J. A. , 'Rates of growth of human solid neoplasms: part I ' (1995 ) 60 J. Surg. Oncol. : 137 -146.

    • Search Google Scholar
  • Shackney, S. E., McCormack, G. W., Cuchural, G. J. Jr.: Growth rate patterns of solid tumors and their relation to responsiveness to therapy: an analytical review. Ann. Intern. Med., 1978, 89 , 107–121.

    Cuchural G. J. , 'Growth rate patterns of solid tumors and their relation to responsiveness to therapy: an analytical review ' (1978 ) 89 Ann. Intern. Med. : 107 -121.

    • Search Google Scholar
  • Spratt, J. S., Spratt, J. A.: What is breast cancer doing before we can detect it? J. Surg. Oncol., 1985, 30 , 156–160.

    Spratt J. A. , 'What is breast cancer doing before we can detect it? ' (1985 ) 30 J. Surg. Oncol. : 156 -160.

    • Search Google Scholar
  • Haskell, C. M.: Thorax. Unknown primary-breast cancer in cancer treatment, 2nd ed. WB Saunders Company, 1985.

  • Anderson, T. J., Battersby, S., King, R. J. B. és mtsai: Oral contraceptive use influences resting breast proliferation. Hum. Pathol., 1989, 20 , 1139–1144.

    King R. J. B. , 'Oral contraceptive use influences resting breast proliferation ' (1989 ) 20 Hum. Pathol. : 1139 -1144.

    • Search Google Scholar
  • Cutuli, B., Dhermain, F., Magrini, S. M. és mtsai: Breast cancer occurred after treatment for Hodgkin’s disease: analysis of 133 cases. Radiother. Oncol., 2001, 59 , 247–255.

    Magrini S. M. , 'Breast cancer occurred after treatment for Hodgkin’s disease: analysis of 133 cases ' (2001 ) 59 Radiother. Oncol. : 247 -255.

    • Search Google Scholar
  • Gallus, S., Bosetti, C., Franceschi, S. és mtsai: Oesophageal cancer in women: tobacco, alcohol, nutritional and hormonal factors. Br. J. Cancer, 2001, 85 , 341–345.

    Franceschi S. , 'Oesophageal cancer in women: tobacco, alcohol, nutritional and hormonal factors ' (2001 ) 85 Br. J. Cancer : 341 -345.

    • Search Google Scholar
  • La Vecchia, C., D’Avanzo, B., Franceschi, S. és mtsai: Menstrual and reproductive factors and gastric-cancer risk in women. Int. J. Cancer, 1994, 59 , 761–764.

    Franceschi S. , 'Menstrual and reproductive factors and gastric-cancer risk in women ' (1994 ) 59 Int. J. Cancer : 761 -764.

    • Search Google Scholar
  • Rodriguez, C., Feigelson, H. S., Deka, A. és mtsai: Postmenopausal hormone therapy and lung cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomark & Prev., 2008, 17 , 655–660.

    Deka A. , 'Postmenopausal hormone therapy and lung cancer risk in the Cancer Prevention Study II Nutrition Cohort ' (2008 ) 17 Cancer Epidemiol Biomark & Prev. : 655 -660.

    • Search Google Scholar
  • Castelao, J. E., Yuan, J-M., Skipper, P. L. és mtsai: Gender and smoking-related bladder cancer risk. J. Natl. Cancer Inst., 2001, 93 , 538–545.

    Skipper P. L. , 'Gender and smoking-related bladder cancer risk ' (2001 ) 93 J. Natl. Cancer Inst. : 538 -545.

    • Search Google Scholar
  • Fernandez, E., La Vecchia, C., Balducci, A. és mtsai: Oral contraceptives and colorectal cancer risk: a meta-analysis. Br. J. Cancer, 2001, 84 , 722–727.

    Balducci A. , 'Oral contraceptives and colorectal cancer risk: a meta-analysis ' (2001 ) 84 Br. J. Cancer : 722 -727.

    • Search Google Scholar
  • Parazzini, F., La Vecchia, C., Negri, E. és mtsai: Case-control study of estrogen replacement therapy and risk of cervical cancer. Br. Med. J., 1997, 315 , 85–88.

    Negri E. , 'Case-control study of estrogen replacement therapy and risk of cervical cancer ' (1997 ) 315 Br. Med. J. : 85 -88.

    • Search Google Scholar
  • Riggs, B. L., Hartmann, L. C.: Selective estrogen-receptor modulators – Mechanisms of action and application to clinical practice. NEJM, 2003, 348 , 618–629.

    Hartmann L. C. , 'Selective estrogen-receptor modulators – Mechanisms of action and application to clinical practice ' (2003 ) 348 NEJM : 618 -629.

    • Search Google Scholar
  • Suba, Zs.: Estrogen deficiency as cancer risk factor. Chapter 5. In Estrogen versus cancer. Nova Science Publishers, Inc., New York, 2009, (in press).

    Suba Zs. , '', in Estrogen versus cancer , (2009 ) -.

  • Suba, Zs.: Systemic risk factors for oral cancer: Estrogen deficiency and insulin resistance. In Progress in oral cancer research. Ed.: Frederik L. Nielsen. Nova Science Publishers, New York, 2008, 157–172.

    Suba Zs. , '', in Progress in oral cancer research , (2008 ) -.

  • Coulam, C. B., Annegers, J. F., Kranz, J. S.: Chronic anovulation syndrome and associated neoplasia. Obstet. Gynecol., 1983, 61 , 403–407.

    Kranz J. S. , 'Chronic anovulation syndrome and associated neoplasia ' (1983 ) 61 Obstet. Gynecol. : 403 -407.

    • Search Google Scholar
  • Hartge, P.: Abortion, breast cancer and epidemiology. N. Engl. J. Med., 1997, 336 , 127–128.

    Hartge P. , 'Abortion, breast cancer and epidemiology ' (1997 ) 336 N. Engl. J. Med. : 127 -128.

    • Search Google Scholar
  • Pierpoint, T., McKeigue, P. M., Isaacs, A. J. és mtsai: Mortality of women with polycystic ovary syndrome at long-term follow-up. J. Clin. Epidemiol., 1998, 51 , 581–586.

    Isaacs A. J. , 'Mortality of women with polycystic ovary syndrome at long-term follow-up ' (1998 ) 51 J. Clin. Epidemiol. : 581 -586.

    • Search Google Scholar
  • Gadducci, A., Gargini, A., Palla, E. és mtsai: Polycystic ovary syndrome and gynecological cancers: is there a link? Gynecol. Endocrinol., 2005, 20 , 200–208.

    Palla E. , 'Polycystic ovary syndrome and gynecological cancers: is there a link? ' (2005 ) 20 Gynecol. Endocrinol. : 200 -208.

    • Search Google Scholar
  • Sartor, B. M., Dickey, R. P.: Polycystic ovarian syndrome and the metabolic syndrome. Am. J. Med., 2005, 330 , 336–342.

    Dickey R. P. , 'Polycystic ovarian syndrome and the metabolic syndrome ' (2005 ) 330 Am. J. Med. : 336 -342.

    • Search Google Scholar
  • Spritzer, P. M., Morsch, D. M., Wiltgen, D.: Polycystic ovary syndrome associated neoplasms. Arq. Bras. Endocrinol. Metabol., 2006, 49 , 805–810.

    Wiltgen D. , 'Polycystic ovary syndrome associated neoplasms ' (2006 ) 49 Arq. Bras. Endocrinol. Metabol. : 805 -810.

    • Search Google Scholar
  • Nestler, J. E., Strauss, J. F.: Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrin Metab. Clin. North Amer., 1991, 20 , 807–823.

    Strauss J. F. , 'Insulin as an effector of human ovarian and adrenal steroid metabolism ' (1991 ) 20 Endocrin Metab. Clin. North Amer. : 807 -823.

    • Search Google Scholar
  • Polson, D. W., Wadsworth, J., Adams, J. és mtsai: Polycystic ovaries: a common finding in normal women. Lancet, 1988, 1 , 870–872.

    Adams J. , 'Polycystic ovaries: a common finding in normal women ' (1988 ) 1 Lancet : 870 -872.

    • Search Google Scholar
  • Carmina, E., Lobo, R. A.: Polycystic ovaries in hirsute women with normal menses. Am. J. Med., 2001, 111 , 602–606.

    Lobo R. A. , 'Polycystic ovaries in hirsute women with normal menses ' (2001 ) 111 Am. J. Med. : 602 -606.

    • Search Google Scholar
  • Farquhar, C. M., Birdsall, M., Manning, P. és mtsai: The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aus. NZ Obstet. Gynaecol., 1994, 34 , 67–72.

    Manning P. , 'The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women ' (1994 ) 34 Aus. NZ Obstet. Gynaecol. : 67 -72.

    • Search Google Scholar
  • Llewellyn, C. D., Johnson, N. W., Warnakulasuriya, K. A. A. S.: Risk factors for squamous cell carcinoma of the oral cavity in young people – a comprehensive literature review. Oral Oncol., 2001, 37 , 401–418.

    Warnakulasuriya K. A. A. S. , 'Risk factors for squamous cell carcinoma of the oral cavity in young people – a comprehensive literature review ' (2001 ) 37 Oral Oncol. : 401 -418.

    • Search Google Scholar
  • Björnström, L., Sjöberg, M.: Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes. Molecular Endocrinology, 2005, 19 , 833–842.

    Sjöberg M. , 'Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes ' (2005 ) 19 Molecular Endocrinology : 833 -842.

    • Search Google Scholar
  • Pillay, O. C., Te Fong, L. F., Crow, J. C.: The association between polycystic ovaries and endometrial cancer. Human Reprod., 2006, 21 , 924–929.

    Crow J. C. , 'The association between polycystic ovaries and endometrial cancer ' (2006 ) 21 Human Reprod. : 924 -929.

    • Search Google Scholar
  • Miller, W. R., O’Neill, J.: The importance of local synthesis of estrogen within the breast. Steroids, 1987, 50 , 537–548.

    O’Neill J. , 'The importance of local synthesis of estrogen within the breast ' (1987 ) 50 Steroids : 537 -548.

    • Search Google Scholar
  • Santen, R. J., Martel, J., Hoagland, M. és mtsai: Stromal spindle cells contain aromatase in human breast-tumors. J. Clin. Endocrin. Metab., 1994, 79 , 627–632.

    Hoagland M. , 'Stromal spindle cells contain aromatase in human breast-tumors ' (1994 ) 79 J. Clin. Endocrin. Metab. : 627 -632.

    • Search Google Scholar
  • MacMahon, B.: Risk factors for endometrial cancer. Gynecol. Oncol., 1974, 2 , 122–129.

    MacMahon B. , 'Risk factors for endometrial cancer ' (1974 ) 2 Gynecol. Oncol. : 122 -129.

  • McCullough, L. D., Blizzard, K., Simpson, E. R. és mtsai: Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection. J. Neurosci., 2003, 23 , 8701–8705.

    Simpson E. R. , 'Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection ' (2003 ) 23 J. Neurosci. : 8701 -8705.

    • Search Google Scholar
  • Van Landeghem, A. A. J., Poortman, J., Nabuurs, M. és mtsa: Endogenous concentration and subcellular distribution of estrogens in normal and malignant breast tissue. Cancer Res., 1985, 45 , 2900–2906.

    Nabuurs M. , 'Endogenous concentration and subcellular distribution of estrogens in normal and malignant breast tissue ' (1985 ) 45 Cancer Res. : 2900 -2906.

    • Search Google Scholar
  • Liehr, J. G.: Is estradiol a genotoxic and mutagenic carcinogen? Endocrine Rev., 2000, 21 , 40–54.

    Liehr J. G. , 'Is estradiol a genotoxic and mutagenic carcinogen? ' (2000 ) 21 Endocrine Rev. : 40 -54.

    • Search Google Scholar
  • Faustini-Fustini, M., Rochira, V., Carani, C.: Oestrogen deficiency in men: where are we today? Eur. J. Endocrinol., 1999, 140 , 111–129.

    Carani C. , 'Oestrogen deficiency in men: where are we today? ' (1999 ) 140 Eur. J. Endocrinol. : 111 -129.

    • Search Google Scholar
  • Carani, C., Qin, K., Simoni, M. és mtsai: Effect of testosterone and estradiol a in man with aromatase deficiency. N. Engl. J. Med., 1997, 337 , 91–95.

    Simoni M. , 'Effect of testosterone and estradiol a in man with aromatase deficiency ' (1997 ) 337 N. Engl. J. Med. : 91 -95.

    • Search Google Scholar
  • Smith, E. P., Boyd, J., Frank, G. R. és mtsai: Estrogen resistance caused by a mutation in the estrogen receptor gene in a man. N. Engl. J. Med., 1994, 331 , 1056–1061.

    Frank G. R. , 'Estrogen resistance caused by a mutation in the estrogen receptor gene in a man ' (1994 ) 331 N. Engl. J. Med. : 1056 -1061.

    • Search Google Scholar
  • Driggers, P. H., Segars, J. H.: Estrogen action and cytoplasmic signaling pathways. Part II: The role of growth factors and phosphorylation in estrogen signaling. Trends Endocrin Metab., 2002, 13 , 422–427.

    Segars J. H. , 'Estrogen action and cytoplasmic signaling pathways. Part II: The role of growth factors and phosphorylation in estrogen signaling ' (2002 ) 13 Trends Endocrin Metab. : 422 -427.

    • Search Google Scholar
  • Segars, J., Driggers, P.: Estrogen action and cytoplasmic signaling cascades. Part I: Membrane-associated signaling complexes. Trends Endocrin Metab., 2002, 13 , 349–354.

    Driggers P. , 'Estrogen action and cytoplasmic signaling cascades. Part I: Membrane-associated signaling complexes ' (2002 ) 13 Trends Endocrin Metab. : 349 -354.

    • Search Google Scholar
  • Umayahara, Y., Kawamori, R., Watada, H. és mtsai: Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-l enhancer. J. Biol. Chem., 1994, 269 , 16433–16442.

    Watada H. , 'Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-l enhancer ' (1994 ) 269 J. Biol. Chem. : 16433 -16442.

    • Search Google Scholar
  • Kahlert, S., Neudling, S., van Eickels, M. és mtsai: Estrogen receptor α rapidly activates the IGF-1 receptor pathway. J. Biol. Chem., 2000, 275 , 18447–18453.

    Eickels M. , 'Estrogen receptor α rapidly activates the IGF-1 receptor pathway ' (2000 ) 275 J. Biol. Chem. : 18447 -18453.

    • Search Google Scholar
  • Leung, K. C., Johannson, G., Leong, G. M. és mtsa: Estrogen regulation of growth hormone action. Endocrine Rev., 2004, 25 , 693–721.

    Leong G. M. , 'Estrogen regulation of growth hormone action ' (2004 ) 25 Endocrine Rev. : 693 -721.

    • Search Google Scholar
  • Henderson, B. E., Ross, R., Bernstein, L.: Estrogens as a cause of human cancer. Cancer Res., 1988, 48 , 246–253.

    Bernstein L. , 'Estrogens as a cause of human cancer ' (1988 ) 48 Cancer Res. : 246 -253.

  • Pietras, R. J., Marquez-Garban, D. C.: Membrane-associated estrogen receptor signaling pathways in human cancers. Clin. Cancer Res., 2007, 13 , 4672–4676.

    Marquez-Garban D. C. , 'Membrane-associated estrogen receptor signaling pathways in human cancers ' (2007 ) 13 Clin. Cancer Res. : 4672 -4676.

    • Search Google Scholar
  • Key, T. J., Applyby, P. N., Reeves, G. K. és mtsai: Body mass index, serum sex hormones and breast cancer risk in postmenopausal women. J. Natl. Cancer Inst., 2003, 95 , 1218–1226.

    Reeves G. K. , 'Body mass index, serum sex hormones and breast cancer risk in postmenopausal women ' (2003 ) 95 J. Natl. Cancer Inst. : 1218 -1226.

    • Search Google Scholar
  • Marquez, D. C., Pietras, R. J.: Membrane-associated binding sites for estrogen contribute to growth regulation in human breast cancer cells. Oncogene, 2001, 20 , 5420–5430.

    Pietras R. J. , 'Membrane-associated binding sites for estrogen contribute to growth regulation in human breast cancer cells ' (2001 ) 20 Oncogene : 5420 -5430.

    • Search Google Scholar
  • Skov, B. G., Fischer, B. M., Pappot, H.: Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival. Lung Cancer, 2008, 59 , 88–94.

    Pappot H. , 'Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival ' (2008 ) 59 Lung Cancer : 88 -94.

    • Search Google Scholar
  • Rodriguez, C., Feigelson, H. S., Deka, A. és mtsai: Postmenopausal hormone therapy and lung cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomark & Prev., 2008, 17 , 655–660.

    Deka A. , 'Postmenopausal hormone therapy and lung cancer risk in the Cancer Prevention Study II Nutrition Cohort ' (2008 ) 17 Cancer Epidemiol Biomark & Prev. : 655 -660.

    • Search Google Scholar
  • Stoner, M., Wang, F., Wormke, M. és mtsai: Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteins. J. Biol. Chem., 2000, 275 , 22769–22779.

    Wormke M. , 'Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteins ' (2000 ) 275 J. Biol. Chem. : 22769 -22779.

    • Search Google Scholar
  • Massarweh, S., Osborne, C. K., Creighton, C. J. és mtsai: Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function. Cancer Res., 2008, 68 , 826–833.

    Creighton C. J. , 'Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function ' (2008 ) 68 Cancer Res. : 826 -833.

    • Search Google Scholar

 

The author instructions are available in PDF.
Instructions for Authors in Hungarian HERE.

 

Mendeley citation style is available HERE.
  • Impact Factor (2019): 0.497
  • Scimago Journal Rank (2018): 0.176
  • SJR Hirsch-Index (2018): 20
  • SJR Quartile Score (2018): Q3 Medicine (miscellaneous)
  • Impact Factor (2018): 0.564
  • Scimago Journal Rank (2018): 0.193
  • SJR Hirsch-Index (2018): 18
  • SJR Quartile Score (2018): Q3 Medicine (miscellaneous)

Language: Hungarian

Founded in 1857
Publication: Weekly, one volume of 52 issues annually

Senior editors

Editor(s)-in-Chief: Papp Zoltán

Read the professional career of Papp Zoltán HERE.

 

Editorial Board

Click for the Editorial Board

Akadémiai Kiadó
Address: Prielle Kornélia u. 21-35. H-1117 Budapest, Hungary
Phone: (+36 1) 464 8235 ---- Fax: (+36 1) 464 8221
Email: orvosihetilap@akkrt.hu